Transoral robotic supraglottic laryngectomy: Long-term functional and oncologic outcomes

dc.authoridGul, Fatih/0000-0001-7992-0974
dc.authorwosidGul, Fatih/K-5017-2019
dc.contributor.authorMuderris, Togay
dc.contributor.authorSevil, Ergun
dc.contributor.authorGul, Fatih
dc.date.accessioned2024-03-09T18:48:18Z
dc.date.available2024-03-09T18:48:18Z
dc.date.issued2024
dc.departmentİzmir Bakırçay Üniversitesien_US
dc.description.abstractObjectives: Minimally invasive transoral organ preservation surgeries are being increasingly used for supraglottic tumors. This study investigates the long-term functional and oncologic outcomes of transoral robotic supraglottic laryngectomy (TORS-SGL).Materials and methods: Twenty-three patients with supraglottic laryngeal cancer who underwent TORS-SGL be-tween 2012 and 2015 at a tertiary referral hospital were retrospectively analyzed with at least 5 years of follow-up. The head and neck tumor council and the multidisciplinary oncological board decided whether the patients were suitable for robotic surgery, and the necessity of adjuvant radiotherapy or chemotherapy. Inclusion criteria was histopathological diagnosis of squamous cell carcinoma of the larynx.Results: Twenty-one patients with T1-T3 supraglottic squamous cell carcinoma were included in this study. Mean follow-up was 48.8 months. Local control was 94.4 % at 2 years and 85.9 % at 5 years. Disease-free survival and overall survival were 85.7 % and 81 % at 2 years and 69.3 % and 57.1 % at 5 years, respectively. There was no permanent tracheostomy or prolonged swallowing dysfunction among patients. Age, perineural and lympho-vascular invasion were found to be risk factors affecting overall survival.Conclusion: TORS-SGL is a feasible, safe and reliable approach with excellent functional results for T1, T2, and selected T3 supraglottic tumors, providing acceptable long-term oncologic results when compared to alternative treatment modalities.en_US
dc.identifier.doi10.1016/j.amjoto.2023.104105
dc.identifier.issn0196-0709
dc.identifier.issn1532-818X
dc.identifier.issue1en_US
dc.identifier.pmid37977058en_US
dc.identifier.scopus2-s2.0-85176731606en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.amjoto.2023.104105
dc.identifier.urihttps://hdl.handle.net/20.500.14034/1281
dc.identifier.volume45en_US
dc.identifier.wosWOS:001119017500001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherW B Saunders Co-Elsevier Incen_US
dc.relation.ispartofAmerican Journal of Otolaryngologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTransoral Robotic Surgery; Supraglottic Laryngectomy; Laryngeal Cancer; Survival; Functional Outcomesen_US
dc.titleTransoral robotic supraglottic laryngectomy: Long-term functional and oncologic outcomesen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
1281.pdf
Boyut:
865.8 KB
Biçim:
Adobe Portable Document Format